Using mixed reality to improve quality of life for people with Parkinson's disease
The Effectiveness of Mixed Reality as Interventional Tool for the Improvement on Quality of Life for People With Parkinson´s Disease. Randomized Control Trial
This study is testing whether a new mixed reality program can improve the quality of life and motivation for people with Parkinson's disease compared to regular physiotherapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 15 (estimated) |
| Ages | 60 Years to 100 Years |
| Sex | All |
| Sponsor | University of Nicosia Academic / other |
| Locations | 1 site (Nicosia, Engomi) |
| Trial ID | NCT06459154 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of a mixed reality program compared to traditional physiotherapy in enhancing the quality of life and motivation of individuals with Parkinson's disease. The research involves two phases: the first focuses on adapting a motivation assessment tool for Greek speakers, while the second phase is a randomized, blinded trial with 45 patients. Participants will engage with innovative mixed reality technology designed to provide interactive rehabilitation experiences. The goal is to determine if this modern approach can lead to better outcomes than conventional methods.
Who should consider this trial
Good fit: Ideal candidates are individuals over 60 years old with independent gait and normal cognitive ability who are native Greek speakers.
Not a fit: Patients with other neurological diseases, uncontrolled circulatory conditions, or those requiring walking aids may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the quality of life and motivation for patients with Parkinson's disease.
How similar studies have performed: While mixed reality is a novel approach in this context, similar studies in other areas have shown promising results, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
For the first interventional phase: Inclusion Criteria: 1\. Male and female over 18 years old 2. Persons with independent gait 3. Normal cognitive ability 5. Greek Native language Exclusion Criteria: 1. Presence of neurological disease 2. Presence of uncontrolled diseases of the circulatory system 3. History of musculoskeletal surgery in the last 6 months 4. Use of a walking aid 5. Partial or total blindness For the second interventional phase: Inclusion Criteria: 1. Male and female over 60 years old 2. Persons with independent gait 3. Normal cognitive ability 5\. Greek Native language Exclusion Criteria: 1. Presence of neurological disease 2. Presence of uncontrolled diseases of the circulatory system 3. History of musculoskeletal surgery in the last 6 months 4. Use of a walking aid 5. Partial or total blindness
Where this trial is running
Nicosia, Engomi
- University of Nicosia — Nicosia, Engomi, Cyprus (Recruiting)
Study contacts
- Principal investigator: Elena Papamichael, PhD Cand — University of Nicosia
- Study coordinator: Elena Papamichael, PhD Cand
- Email: papamichael.e1@live.unic.ac.cy
- Phone: 99886346
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.